A largely overlooked plant compound found in common fruits and vegetables is drawing new scientific attention for its potential effects on aging and brain health.
Progress is accelerating but clarity isn’t always keeping up.
Check out our new sponsor, NADclinic at nadclinic.com. They are the one-stop-shop marketplace for longevity, and pioneers in NAD+ solutions.
From longevity and AI to the future of healthcare, innovation is moving fast but understanding is still catching up. The result is a growing tension between what’s being promised and what’s actually proven.
Today, David Ewing Duncan brings a grounded, big-picture perspective on these shifts. Drawing from his work at the intersection of science, technology, and human behavior, he explores why skepticism is rising, how hype can distort progress, and what it really means to live in an era of rapid innovation.
The conversation goes beyond longevity touching on self-awareness, the limits of current science, the role of AI, and how we can think more critically about the future we’re building.
Are we asking better questions or just chasing better tools?
David Ewing Duncan is an award-winning science journalist, bestselling author, and speaker known for exploring the intersection of health, technology, and the future of human life.
What You’ll Learn
While it seems logical that age-related cognitive decline would be blamed on brain aging and degeneration (which, like anything in the brain, is notoriously hard to treat), there’s some evidence that processes elsewhere in the body influence the brain’s ability to form memories. In particular, neuronal pathways that sense the status of other organs in the body can influence cognitive functions in the brain.
Other studies have shown that our gut microbiome affects learning, memory, and behavior. But what we don’t yet understand is how these connections work—the specific molecules, microbes, and gut-brain communication involved—and whether we can use that knowledge to prevent or reverse age-related memory loss.
In our new work published today in Nature, we discovered that the aging gastrointestinal tract produces specific molecules that blunt the activity of a key gut-brain neuronal pathway, leading to age-related cognitive decline in mice.
Engineered cells are a high-value genetic asset that is key to many fields, including biotechnology, medicine, aging, and stem cell research, with the global market projected to reach $8.0 trillion USD by 2035. Yet the only ways to keep the cells safe are strong locks and watchful guards.
In Science Advances, a team of U.S. researchers present a new approach to genetically securing precious biological material. They created a genetic combination lock in which the locking or encryption process scrambled the DNA of a cell so that its important instructions were non-functional and couldn’t be easily read or used.
The unlocking, or decryption, process involves adding a series of chemicals in a precise order over time—like entering a password—to activate recombinases, which then unscramble the DNA to their original, functional form.
In a recent Cell Press Blue paper, Zhang et al. identify two polyunsaturated lipids that selectively eliminate senescent cells by inducing ferroptosis, uncovering this iron-dependent cell death pathway as a vulnerability for senescent cells. Their findings position ferroptosis induction as a promising strategy for targeting senescence and aging-associated diseases.
Metformin is a first-line oral antidiabetic agent that has attracted increasing interest as a potential geroprotective therapy due to its ability to improve metabolic homeostasis, reduce oxidative stress, and attenuate chronic inflammation. However, its role in skeletal muscle aging and sarcopenia remains controversial. Observational and epidemiological studies suggest that metformin use is associated with a lower prevalence of sarcopenia, particularly in metabolically compromised or insulin-resistant older populations, where improvements in systemic metabolism and inflammatory burden may indirectly support muscle quality and function.
You just haven’t noticed.
George Church, Harvard geneticist and Human Genome Project pioneer, explains why CRISPR wasn’t the real breakthrough, how multiplex gene editing unlocked organ transplants and de-extinction, and why aging will likely require rewriting many genes at once.
Hosted by Mgoes → https://twitter.com/m_goes_distance
Brought to you by SuperHuman Fund → https://superhuman.fund/
0:00 — Gene Editing Mammals → Humans
8:36 — Germline vs Somatic
14:56 — Modified Humans Are Already Here
18:50 — Enhancing Healthy Humans
25:00 — Aging Therapies vs Cognitive Enhancement
30:20 — Embryo Selection
38:10 — Is US Losing To UAE?
42:33 — Biotech Failures
49:31 — Next Dire Wolf Moment
54:21 — AI x Science
1:02:07 — Synthetizing Entire Genomes.
The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping AI, biotechnology, and human progress.
This episode discusses George Church, gene editing, CRISPR, human enhancement, longevity, aging, embryo selection, synthetic biology, multiplex editing, AI biotech.
The team used advanced imagining techniques to analyse breast tissue from more than 500 women aged 15 to 86 years old. The tissue included biopsies taken from women for non-cancer-related reasons.
Combining these images with details of the hormone receptors and immune cells present, as well as the tissue architecture, the researchers were able to map how breast tissue changes over time in unprecedented detail. Their findings point to reasons why breast cancer risk increases with age and why tumors in younger women differ biologically.
The author added: “Our map revealed that as women age, their breast tissue goes through major changes, with the most dramatic changes occurring at menopause. There are changes, too, during their twenties, possibly linked to pregnancy and childbirth, but these are far less pronounced.”
The map revealed that all types of cells become fewer in number and divide far less often. Milk-producing structures known as lobules shrink or disappear, while the ducts that that carry milk become relatively more common, with the supporting layer around them becoming thicker. Fat cells increase while blood vessels decrease.
Meanwhile, changes occur in the immune environment. Younger breasts have more B cells and active T cells, which helps them identify and kill cancer cells. As tissue ages, these types of cells decline in number, replaced by other types of immune cell that indicate a more inflammatory and potentially less protective immune environment. ScienceMission sciencenewshighlights.
Scientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age – including dramatic changes during menopause.